Literature DB >> 12559805

Factors affecting the compliance of the antenatal hepatitis B screening programme in Italy.

Tommaso Stroffolini1, Elvira Bianco, Andrè Szklo, Rossana Bernacchia, Crescenzo Bove, Mario Colucci, Rosa Cristina Coppola, Paolo D'Argenio, Pierluigi Lopalco, Antonino Parlato, Pietro Ragni, Andrea Simonetti, Carla Zotti, Alfonso Mele.   

Abstract

The effectiveness in the prevention of perinatally transmitted HBV infection was assessed in 11858 pregnant women consecutively recruited in public and private hospitals in six Italian regions during a 2 months period in 2001. Of them 10881 (91.8%) attended HBsAg antenatal screening. The overall HBsAg prevalence was 1.7% (CI 95%: 1.4-1.9); it was 1.4% (CI 95%: 1.2-1.7) in pregnant women born in Italy but 5.9% (CI 95%: 4.1-8.1) in those born in Asia, Africa, central and south America, and eastern Europe. Results of multiple logistic regression analysis indicate that birth in foreign countries (OR 2.0; CI 95%: 1.3-3.0), family size with more than 4 members in the household (OR 3.5; CI 95%:2.7-4.6), and birth in a private hospital (OR 1.9; CI 95%: 1.3-2.8) were all independent predictors of lack of adherence to HBsAg screening. Out of the 182 new-borns of HBsAg positive mothers 172 (95.0%) were given active plus passive immunisation; this figure was 100% in new-borns of foreign mothers. These findings evidence a good effectiveness in the prevention of perinatally transmitted HBV in Italy. More efforts should be addressed to improve the effectiveness of the programme among foreign pregnant women who have high rate of HBsAg and more likely escape HBsAg screening than Italian pregnant women. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12559805     DOI: 10.1016/s0264-410x(02)00439-5

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

1.  Intervening to reduce inequalities in infections in Europe.

Authors:  Jan C Semenza; Johan Giesecke
Journal:  Am J Public Health       Date:  2008-04-01       Impact factor: 9.308

2.  Economic analysis of the first 20 years of universal hepatitis B vaccination program in Italy: an a posteriori evaluation and forecast of future benefits.

Authors:  Sara Boccalini; Cristina Taddei; Vega Ceccherini; Angela Bechini; Miriam Levi; Dario Bartolozzi; Paolo Bonanni
Journal:  Hum Vaccin Immunother       Date:  2013-02-01       Impact factor: 3.452

3.  Impact of hepatitis B vaccination in children born to HBsAg-positive mothers: a 20-year retrospective study.

Authors:  L Bracciale; M Fabbiani; A Sansoni; L Luzzi; L Bernini; G Zanelli
Journal:  Infection       Date:  2009-07-23       Impact factor: 3.553

4.  Hepatitis B and immigrants: a SIMIT multicenter cross-sectional study.

Authors:  M Fasano; A Saracino; G Carosi; F Mazzotta; N Marino; E Sagnelli; G B Gaeta; G Angarano; G Verucchi; P Bellissima; C Angeletti; T Santantonio
Journal:  Infection       Date:  2012-12-21       Impact factor: 3.553

Review 5.  Chronic hepatitis B in 2014: great therapeutic progress, large diagnostic deficit.

Authors:  Claus Niederau
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

Review 6.  Epidemiology of acute and chronic hepatitis B and delta over the last 5 decades in Italy.

Authors:  Evangelista Sagnelli; Caterina Sagnelli; Mariantonietta Pisaturo; Margherita Macera; Nicola Coppola
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

7.  Epidemiological impact of mandatory vaccination against hepatitis B in Italian young adults.

Authors:  Marcello Campagna; Andrea Siddu; Angelo Meloni; Claudia Murru; Giuseppina Masia; Rosa Cristina Coppola
Journal:  Hepat Mon       Date:  2011-09       Impact factor: 0.660

8.  Adherence to the screening program for HBV infection in pregnant women delivering in Greece.

Authors:  Vassiliki Papaevangelou; Christos Hadjichristodoulou; Dimitrios Cassimos; Maria Theodoridou
Journal:  BMC Infect Dis       Date:  2006-05-09       Impact factor: 3.090

9.  Gaps in the prevention of perinatal transmission of hepatitis B virus between recommendations and routine practices in a highly endemic region: a provincial population-based study in China.

Authors:  Yali Hu; Shu Zhang; Chao Luo; Qilan Liu; Yi-Hua Zhou
Journal:  BMC Infect Dis       Date:  2012-09-17       Impact factor: 3.090

10.  An assessment of the effect of hepatitis B vaccine in decreasing the amount of hepatitis B disease in Italy.

Authors:  Giuseppe La Torre; Nicola Nicolotti; Chiara de Waure; Giacomina Chiaradia; Maria Lucia Specchia; Alice Mannocci; Walter Ricciardi
Journal:  Virol J       Date:  2008-07-24       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.